Patents by Inventor Ola Winqvist

Ola Winqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS
    Publication number: 20240033320
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: December 14, 2022
    Publication date: February 1, 2024
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • VACCINE COMPRISING AN ANTIGEN AND A TLR2 AGONIST
    Publication number: 20230321229
    Abstract: The present invention provides vaccine kits and a method for vaccination using such vaccination kits.
    Type: Application
    Filed: September 3, 2021
    Publication date: October 12, 2023
    Inventors: Ola WINQVIST, Johan SJÖDAHL
  • Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics
    Patent number: 11672842
    Abstract: The present invention relates to the use of a gonadotropin-releasing hormone (including GnRH I, a GnRH I analogue, GnRH II, or a GnRH II analogue) as adjuvant immunotherapeutic.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: June 13, 2023
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Yen Lundgren
  • NOVEL COMPOUNDS (IMMUNORHELINS)
    Publication number: 20230118205
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Application
    Filed: August 16, 2022
    Publication date: April 20, 2023
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immunorhelin compounds for intracellular infections
    Patent number: 11564969
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: January 31, 2023
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (publ)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Compounds (immunorhelins)
    Patent number: 11434258
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 6, 2022
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • METHOD FOR THE EXPANSION OF HPV IMMUNOGEN SPECIFIC T-CELLS
    Publication number: 20220226457
    Abstract: The present invention provides a method for the expansion of HPV immunogen specific T cells, comprising the steps of: i. providing a phagocytosable particle comprising a core and a human papillomavirus (HPV) immunogen tightly associated to the core; wherein the HPV immunogen has an amino acid sequence that corresponds to the amino acid sequence of a HPV protein, or has an amino acid sequence that corresponds to an amino acid sequence of a part of a HPV protein; ii. providing APCs; iii. contacting the phagocytosable particle comprising a core and a HPV immunogen with the APCs from step ii in vitro, and under conditions allowing phagocytosis of the HPV immunogen by the APCs; iv. providing T-cells that have been harvested from a subject; v. contacting the T-cells with the APCs from step iii) in vitro, and under conditions allowing specific activation of HPV immunogen specific T-cells.
    Type: Application
    Filed: December 24, 2019
    Publication date: July 21, 2022
    Inventors: Hans GRONLUND, Ola WINQVIST
  • Use of known compounds—intracellular infections
    Patent number: 11304990
    Abstract: The present invention provides a method of treating intracellular infections, in particular intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: April 19, 2022
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating macrolides
    Patent number: 11059845
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in claim 1. The macrolides have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating macrolides
    Patent number: 11059844
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • Immune stimulating compound
    Patent number: 11059846
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: July 13, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • GONADOTROPIN-RELEASING HORMONES FOR USE AS ADJUVANT IMMUNOTHERAPEUTICS
    Publication number: 20210128672
    Abstract: The present invention relates to the use of a gonadotropin-releasing hormone (including GnRH I, a GnRH I analogue, GnRH II, or a GnRH II analogue) as adjuvant immunotherapeutic.
    Type: Application
    Filed: February 22, 2018
    Publication date: May 6, 2021
    Inventors: Ola Winqvist, Yen Lundgren
  • Immune stimulating macrolide
    Patent number: 10919927
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating viral diseases and cancer.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: February 16, 2021
    Assignee: ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
    Inventors: Ola Winqvist, Robert Wallin, Emma Lindh, Matt Gregory, Steven Moss
  • COMBINATIONS OF MACROLIDE COMPOUNDS AND IMMUNE CHECKPOINT INHIBITORS
    Publication number: 20210040134
    Abstract: The present invention provides a combination of immune stimulating macrolides with checkpoint inhibitors. The combinations have synergistic effects and can be used in treating viral diseases and cancer.
    Type: Application
    Filed: March 25, 2019
    Publication date: February 11, 2021
    Inventor: Ola Winqvist
  • NOVEL IMMUNE STIMULATING MACROLIDES
    Publication number: 20200010498
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
    Type: Application
    Filed: February 22, 2018
    Publication date: January 9, 2020
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL IMMUNE STIMULATING COMPOUND
    Publication number: 20200010499
    Abstract: The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: February 22, 2018
    Publication date: January 9, 2020
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL IMMUNE STIMULATING MACROLIDES
    Publication number: 20190389896
    Abstract: The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in claim 1. The macrolides have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: February 22, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL COMPOUNDS (IMMUNORHELINS - INTRACELLULAR INFECTIONS)
    Publication number: 20190388497
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of activating GnRH receptors when administered to animal or human patients or cells. These immunorhelins have utility in treating intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL COMPOUNDS (IMMUNORHELINS)
    Publication number: 20190389908
    Abstract: The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 26, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss
  • NOVEL USE OF KNOWN COMPOUNDS - INTRACELLULAR INFECTIONS
    Publication number: 20190374598
    Abstract: The present invention provides a method of treating intracellular infections, in particular intracellular bacterial, fungal, and protozoal infections.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 12, 2019
    Inventors: Ola Winqvist, Emma Lindh, Robert Wallin, Matt Gregory, Steven Moss